The aetiology of stones in children differs from that in adults. Young children, especially boys, are prone to infective stones, although this type of calculi is decreasing in frequency over time in prosperous countries. Two monogenic causes, cystinuria and hyperoxaluria, each account for 5–15% of paediatric stones. Increased factors for stone formation in children include prematurity, neurological problems, ketogenic diet and reconstructed or augmented bladders. Hypercalciuria is commonly found in paediatric stone formers, is usually idiopathic and is only rarely associated with hypercalcaemia. All children with stones should undergo a metabolic evaluation.

1.
Coward RJM, Peters CJ, Duffy PG, Corry D, Kellett MJ, Choong S, van’t Hoff WG: Epidemiology of paediatric renal stone disease in the UK. Arch Dis Child 2003;88:962–965.
2.
Monge M, Garcia-Nieto VM, Domenech E, Barac-Nieto M, Muros M, Perez-Gonzalez E: Study of renal metabolic disturbances related to renal lithiasis at school age in very-low-birth-weight children. Nephron 1998;79:269–273.
3.
Schell-Feith EA, Kist-van Holthe JE, Conneman N, van Zwieten PH, Holscher HC, Zonderland HM, Brand R, van der Heijden BJ: Etiology of nephrocalcinosis in preterm neonates: Association of nutritional intake and urinary parameters. Kidney Int 2000;58:2102–2110.
4.
Hoppe B, Hesse A, Neuhaus T, Fanconi S, Blau N, Roth B, Leumann E: Influence of nutrition on urinary oxalate and calcium in preterm and term infants. Pediatr Nephrol 1997;11:687–690.
5.
Roberts JP, Atwell JD: Vesicoureteric reflux and urinary calculi in children. Br J Urol 1989;64:10–12.
6.
Woodhouse CR, Lennon GN: Management and aetiology of stones in intestinal urinary reservoirs in adolescents. Eur Urol 2001;39:253–259.
7.
Rhee BK, Bretan PN Jr, Stoller ML: Urolithiasis in renal and combined pancreas/renal transplant recipients. J Urol 1999;161:1458–1462.
8.
So NP, Osorio AV, Simon SD, Alon US: Normal urinary calcium/creatinine ratios in African-American and Caucasian children. Pediatr Nephrol 2001;16:133–139.
9.
Furth SL, Casey JC, Pyzik PL, Neu AM, Docimo SG, Vining EP, Freeman JM, Fivush BA: Risk factors for urolithiasis in children on the ketogenic diet. Pediatr Nephrol 2000;15:125–128.
10.
Weinstein DA, Somers MJ, Wolfsdorf JI: Decreased urinary citrate excretion in type 1a glycogen storage disease. J Pediatr 2000;138:378–382.
11.
Rodriguez-Soriano J: Hypomagnesaemia of hereditary renal origin. Pediatr Nephrol 1987;1:465–472.
12.
Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, Casari G, Bettinelli A, Colussi G, Rodriguez-Soriano J, McCredie D, Milford D, Sanjad S, Lifton RP: Paracellin-1, a renal tight junction protein required for paracellular Mg2+ reabsorption. Science 1999;285:103–106.
13.
Alon US, Berenbom A: Idiopathic hypercalciuria of childhood: 4- to 11-year outcome. Pediatr Nephrol 2000;14:1011–1015.
14.
Noe HN: Hypercalciuria and pediatric stone recurrences with and without structural abnormalities. J Urol 2000;164:1094–1096.
15.
Polito C, La Manna A, Cioce F, Villani J, Nappi B, Di Toro R: Clinical presentation and natural course of idiopathic hypercalciuria in children. Pediatr Nephrol 2000;15:211–214.
16.
Goodyer P, Saadi I, Ong P, Elkas G, Rozen R: Cystinuria subtype and the risk of nephrolithiasis. Kidney Int 1998;54:56–61.
17.
Neuhaus TJ, Belzer T, Blau N, Hoppe B, Sidhu H, Leumann E: Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child 2000;82:322–326.
18.
Perez-Brayfield MR, Caplan D, Gatti JM, Smith EA, Kirsch AJ: Metabolic risk factors for stone formation in patients with cystic fibrosis. J Urol 2002;167:480–484.
19.
Sidhu H, Hoppe B, Hesse A, Tenbrock K, Bromme S, Rietschel E, Peck AB: Absence of Oxalobacter formigenes in cystic fibrosis patients: A risk factor for hyperoxaluria. Lancet 1998;352:1026–1029.
20.
Cameron JS, Moro F, Simmonds HA: Gout, uric acid and purine metabolism in paediatric nephrology. Paediatr Nephrol 1993;7:105–118.
21.
Perrone HC, dos Santos DR, Santos MV, Pinheiro ME, Toporovski J, Ramos OL, Schor N: Urolithiasis in childhood: metabolic evaluation. Pediatr Nephrol 1992;6:54–56.
22.
Pietrow PK, Pope JC 4th, Adams MC, Shyr Y, Brock JW 3rd: Clinical outcome of pediatric stone disease. J Urol 2002;167:670–673.
23.
Ece A, Ozdemir E, Gurkan F, Dokucu AI, Akdeniz O: Characteristics of pediatric urolithiasis in south-east Anatolia. Intl J Urol 2000;7:330–334.
24.
Rizvi SA, Naqvi SA, Hussain Z, Hashmi A, Hussain M, Zafar MN, Sultan S, Mehdi H. Pediatric urolithiasis: developing nation perspectives. J Urol 2002;168:1522–1525.
25.
Sarkissian A, Babloyan A, Arikyants N, Hesse A, Blau N, Leumann E: Pediatric urolithiasis in Armenia: A study of 198 patients observed from 1991 to 1999. Pediatr Nephrol 2001;16:728–732.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.